共 50 条
- [12] Real-World Clinical Outcomes of Teclistamab and Talquetamab in Relapsed/Refractory Multiple Myeloma (RRMM): A UK Single-Centre Experience CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S92 - S92
- [14] Assessing NP Roles in Talquetamab Treatment for Multiple Myeloma ONCOLOGY-NEW YORK, 2024, 38 (11):